Winrevair
Ended Awarded
- Contract number
- 36C26126N0220
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $20,994
Award facts
- Contract value 100% obligated
- $20,993.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rahway, NJ 07065, USA
Award details come from SAM.gov/FPDS.
About this award
Merck Sharp & Dohme LLC has been awarded a delivery order valued at approximately $21,000 for WINREVAIR under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The award, issued on November 19, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of January 19, 2026. The contract will be performed in Rahway, New Jersey, where Merck maintains its headquarters. This award was made without a set-aside designation, indicating an open and competitive procurement process. The funding agency is Veterans Integrated Service Network 21, a component of the Department of Veterans Affairs, which has established Merck as a strategic partner in federal pharmaceutical procurement through its $5.8 billion Federal Supply Schedule contract.
This delivery order represents a specific pharmaceutical product pull from Merck's existing GSA Schedule contract, enabling the Department of Veterans Affairs to procure WINREVAIR for veteran healthcare needs. Merck has demonstrated significant capacity as a federal pharmaceutical supplier, maintaining multiple high-value indefinite delivery vehicles across agencies including the CDC, HHS, and DoD, with products spanning vaccines, cancer treatments, and infectious disease medications. The abbreviated contract ceiling of $20,994 reflects a discrete product requirement within the Veterans Affairs system's broader pharmaceutical acquisition framework.
Quick answers
Who was awarded contract 36C26126N0220?
36C26126N0220 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on November 19, 2025.
How much is contract 36C26126N0220 worth?
The government has obligated $20,994 on 36C26126N0220.
Is contract 36C26126N0220 an order under another contract?
Yes. 36C26126N0220 is a delivery order under 36F79725D0146, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0220 competed?
The extent of competition for 36C26126N0220 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award